Skip to main content
Figure 6 | BMC Complementary and Alternative Medicine

Figure 6

From: A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways

Figure 6

Corilagin inhibits the secretion of TGF-β1 in ovarian cancer cells. (A) The TGF-β1 secretion of three ovarian cancer cell lines, HO8910PM, SKOv3ip and Hey, was inhibited by Corilagin in a dose-dependent manner. The experiments were repeated three times (*P<0.05 or **P<0.01, compared with the untreated control cells). (B) Both Corilagin (40 μM) and Paclitaxel (40 nM) inhibited Hey cell growth. Experiments were repeated three times (*P<0.05 compared with untreated control cells). (C) Corilagin, but not Paclitaxel, inhibited the secretion of TGF-β1 in Hey cells. Experiments were repeated three times (*P<0.05 compared with untreated control cells).

Back to article page